Compare AANJANEYA LIFECARE with Orchid Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ORCHID PHARMA - Comparison Results

ORCHID PHARMA 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ORCHID PHARMA DR. DATSONS LABS/
ORCHID PHARMA
 
P/E (TTM) x -10.9 -23.6 - View Chart
P/BV x 0.2 6.8 2.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   ORCHID PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ORCHID PHARMA
Sep-13
DR. DATSONS LABS/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs126194 64.7%   
Low Rs3135 88.3%   
Sales per share (Unadj.) Rs133.0276.5 48.1%  
Earnings per share (Unadj.) Rs0.2-79.2 -0.2%  
Cash flow per share (Unadj.) Rs6.6-43.5 -15.2%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.853.9 238.8%  
Shares outstanding (eoy) m31.6670.45 44.9%   
Bonus/Rights/Conversions FCCBESOP-  
Price / Sales ratio x0.60.4 142.1%   
Avg P/E ratio x516.1-1.4 -35,704.7%  
P/CF ratio (eoy) x11.8-2.6 -449.4%  
Price / Book Value ratio x0.62.1 28.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4778,067 30.7%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m562,527 2.2%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m4,21119,477 21.6%  
Other income Rs m79407 19.3%   
Total revenues Rs m4,28919,884 21.6%   
Gross profit Rs m5691,103 51.6%  
Depreciation Rs m2042,519 8.1%   
Interest Rs m4305,227 8.2%   
Profit before tax Rs m13-6,236 -0.2%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m6-125 -4.9%   
Profit after tax Rs m5-5,580 -0.1%  
Gross profit margin %13.55.7 238.5%  
Effective tax rate %48.02.0 2,392.4%   
Net profit margin %0.1-28.7 -0.4%  
BALANCE SHEET DATA
Current assets Rs m6,85211,014 62.2%   
Current liabilities Rs m6,71132,060 20.9%   
Net working cap to sales %3.3-108.1 -3.1%  
Current ratio x1.00.3 297.2%  
Inventory Days Days16195 169.5%  
Debtors Days Days31834 949.1%  
Net fixed assets Rs m3,67329,440 12.5%   
Share capital Rs m317705 44.9%   
"Free" reserves Rs m3,7612,043 184.1%   
Net worth Rs m4,0783,800 107.3%   
Long term debt Rs m1,6719,018 18.5%   
Total assets Rs m12,63346,510 27.2%  
Interest coverage x1.0-0.2 -533.1%   
Debt to equity ratio x0.42.4 17.3%  
Sales to assets ratio x0.30.4 79.6%   
Return on assets %3.4-0.8 -453.1%  
Return on equity %0.1-146.9 -0.1%  
Return on capital %7.7-3.7 -205.5%  
Exports to sales %22.937.9 60.4%   
Imports to sales %14.322.6 63.2%   
Exports (fob) Rs m9647,378 13.1%   
Imports (cif) Rs m6024,406 13.7%   
Fx inflow Rs m9647,513 12.8%   
Fx outflow Rs m6075,649 10.7%   
Net fx Rs m3571,865 19.1%   
CASH FLOW
From Operations Rs m1,3451,682 80.0%  
From Investments Rs m-2,256-9,860 22.9%  
From Financial Activity Rs m-1,2006,644 -18.1%  
Net Cashflow Rs m-2,111-1,535 137.5%  

Share Holding

Indian Promoters % 4.5 32.3 14.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.6 -  
FIIs % 1.4 3.3 40.9%  
ADR/GDR % 0.0 4.6 -  
Free float % 94.1 55.3 170.2%  
Shareholders   20,807 84,811 24.5%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  AUROBINDO PHARMA  IPCA LABS  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Lower; Dow Futures Up by 90 Points(12:30 pm)

Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 34 points, up 0.1% at 48,844 levels.

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

Buzzing Sectors Before Budget 2021(Fast Profits Daily)

Jan 12, 2021

The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.

Here's Why Smallcaps Could Be Your Best Investment in 2021(Profit Hunter)

Jan 12, 2021

Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS